BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 26218725)

  • 1. Laboratory errors leading to nonmelanoma skin cancer recurrence after Mohs micrographic surgery.
    Zabielinski M; Leithauser L; Godsey T; Gloster HM
    Dermatol Surg; 2015 Aug; 41(8):913-6. PubMed ID: 26218725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center.
    Chong T; Tristani-Firouzi P; Bowen GM; Hadley ML; Duffy KL
    Dermatol Surg; 2015 Aug; 41(8):889-95. PubMed ID: 26066619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using frozen section margin control technique to manage non-melanomatous skin lesions in high-risk sites.
    Nizamoglu M; Douglas H; McArdle C; Mathew B; Vize C; Matteucci P
    J Plast Reconstr Aesthet Surg; 2016 May; 69(5):657-62. PubMed ID: 26850755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mohs micrographic surgery for the management of nonmelanoma skin cancers.
    Cumberland L; Dana A; Liegeois N
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):325-35. PubMed ID: 19698914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mohs micrographic surgery local recurrences.
    Hruza GJ
    J Dermatol Surg Oncol; 1994 Sep; 20(9):573-7. PubMed ID: 8089356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of dermoscopy in Mohs micrographic surgery (MMS) for nonmelanoma skin cancer (NMSC).
    Yeom SD; Lee SH; Ko HS; Chung KY; Shin J; Choi GS; Byun JW
    Int J Dermatol; 2017 Jun; 56(6):e136-e139. PubMed ID: 28247925
    [No Abstract]   [Full Text] [Related]  

  • 7. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.
    Snow SN; Gordon EM; Larson PO; Bagheri MM; Bentz ML; Sable DB
    Cancer; 2004 Jul; 101(1):28-38. PubMed ID: 15221986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective audit of patients referred for further treatment following Mohs surgery for non-melanoma skin cancer.
    Wee E; Goh MS; Estall V; Tiong A; Webb A; Mitchell C; Murray W; Tran P; McCormack CJ; Henderson M; Hiscutt EL
    Australas J Dermatol; 2018 Nov; 59(4):302-308. PubMed ID: 29349770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary on laboratory errors leading to nonmelanoma skin cancer recurrence following Mohs micrographic surgery.
    Lee KC; Eisen DB
    Dermatol Surg; 2015 Aug; 41(8):917-8. PubMed ID: 26166261
    [No Abstract]   [Full Text] [Related]  

  • 10. Mohs micrographic surgery: a synopsis.
    Stone JL
    Hawaii Med J; 1993 May; 52(5):134-9. PubMed ID: 8320092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
    Cherpelis BS; Turner L; Ladd S; Glass LF; Fenske NA
    Dermatol Surg; 2009 Jul; 35(7):1050-6. PubMed ID: 19469800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population.
    Viola KV; Jhaveri MB; Soulos PR; Turner RB; Tolpinrud WL; Doshi D; Gross CP
    Arch Dermatol; 2012 Apr; 148(4):473-7. PubMed ID: 22508870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mohs micrographic surgery concordance between Mohs surgeons and dermatopathologists.
    Semkova K; Mallipeddi R; Robson A; Palamaras I
    Dermatol Surg; 2013 Nov; 39(11):1648-52. PubMed ID: 24581313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining recurrence of nonmelanoma skin cancer after Mohs micrographic surgery: Report of the American College of Mohs Surgery Registry and Outcomes Committee.
    Leitenberger JJ; Rogers H; Chapman JC; Maher IA; Fox MC; Harmon CB; Bailey EC; Odland P; Wysong A; Johnson T; Wisco OJ
    J Am Acad Dermatol; 2016 Nov; 75(5):1022-1031. PubMed ID: 27546292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mohs' micrographic surgery for nonmelanoma skin cancers.
    Nelson BR; Railan D; Cohen S
    Clin Plast Surg; 1997 Oct; 24(4):705-18. PubMed ID: 9342512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of paraffin sections in association with Mohs micrographic surgery for nonmelanoma skin cancers.
    Ebede TL; Lee EH; Dusza SW; Busam KJ; Nehal KS
    Dermatol Surg; 2012 Oct; 38(10):1631-8. PubMed ID: 22958072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: A prospective review.
    Kyllo RL; Staser KW; Rosman I; Council ML; Hurst EA
    J Am Acad Dermatol; 2019 Aug; 81(2):541-547. PubMed ID: 31230975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of periocular basal and squamous cell carcinoma: a series of 485 cases.
    Nemet AY; Deckel Y; Martin PA; Kourt G; Chilov M; Sharma V; Benger R
    Am J Ophthalmol; 2006 Aug; 142(2):293-7. PubMed ID: 16876511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial.
    Smeets NW; Krekels GA; Ostertag JU; Essers BA; Dirksen CD; Nieman FH; Neumann HA
    Lancet; 2004 Nov 13-19; 364(9447):1766-72. PubMed ID: 15541449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basosquamous carcinoma and metatypical basal cell carcinoma: a review of treatment with Mohs micrographic surgery.
    Allen KJ; Cappel MA; Killian JM; Brewer JD
    Int J Dermatol; 2014 Nov; 53(11):1395-403. PubMed ID: 24961583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.